CDH1 and cancer: EMT leads to cancer cells losing epithelial markers, such as E-cadherin, α-catenin, and γ-catenin, and gaining mesenchymal markers fibronectin, vimentin, and N-cadherin, leading epithelial cancer cells to become more invasive and gain metastatic capabilities.